angiotensin ii has been researched along with n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, Y; Hu, B; Rong, N; Yang, R; Zhang, J; Zhang, Q; Zhang, W | 1 |
1 other study(ies) available for angiotensin ii and n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea
Article | Year |
---|---|
Angiotensin II degrades myeloid cell leukemia 1 in human umbilical vein endothelial cells.
Topics: Angiotensin II; Cell Survival; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Human Umbilical Vein Endothelial Cells; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; Thiazoles; Urea | 2017 |